A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) and Harvard Medical School has identified seven genetic risk factors?DNA sequences carried by some people but not others?that predict risk for prostate cancer.
A new report released by the Institute of Medicine (IOM) shows that the fight against AIDS is being undermined by the requirement that most US funding to address sexual transmission of HIV go to abstinence-until-marriage programs.
The Food and Drug Administration (FDA) notified Hill’s Pet Nutrition, Inc., of Topeka, Kansas, that FDA testing has detected melamine and melamine byproducts in wheat gluten received by the company to make dry cat food.
In the past week, national figures Elizabeth Edwards and Tony Snow have brought much needed focus on the diagnosis and treatment of cancer. The challenge is to overcome patient fear and encourage qualified second opinions.
Scientists at Dana-Farber Cancer Institute have shown in a laboratory study that revving up a crucial set of muscle genes counteracts the damage caused by a form of muscular dystrophy.
“An accessible view of the inner workings of the human brain for the nonscientist reader … a masterful job of bridging the ever-widening gulf between science and the general public” said Margaret McFall-Ngai, professor, University of Wisconsin Madison School of Medicine and Public Health.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug.
The European Medicines Agency (EMEA) has recommended restrictions on the use of Ketek (telithromycin) in three of its four approved indications.
The BMA is launching updated guidance on withholding and withdrawing life-prolonging treatment, to take into account the major changes for patients and doctors that will come into force when the Mental Capacity Act is implemented in England and Wales in April and October 2007.
Who would have guessed that when the Star Trek medical diagnostic tool known as the tricorder makes its appearance in real life, the first user might be . . . your dentist.